Close Navigation
About ArixStrategy
OverviewInvestment caseNewsResultsDocumentsEventsCalendarAnalystsStock infoContact
AboutStrategyTeamPortfolioInsightsMediaContact
Investors
AboutStrategyTeamPortfolioInsightsMediaContact
Investors
Overlay

Autolus Therapeutics Reports First Quarter 2020 Financial Results and Operational Progress

7th May 2020

Portfolio

This post references, or is about Autolus. Find out more by clicking below

London, UK

Useful Tools

Download, print or share this article

Print Print Article Email Email Article
Print Save Article

Stay Updated

Add your email below to stay updated with useful and informative content from Arix and our portfolio companies

Share Article
TwitterTwitterLinkedInLinkedInFacebookFacebook

Arix Bioscience

About Arix

The Team

Portfolio

Partners

Insights

News & Events

Contact

Investor Relations

Results Centre

Financial Calendar

Regulatory News

Document Library

Analysts & Advisors

Shareholder Information

Meta

Privacy Policy

Terms of use

Cookie Policy

Arix Bioscience
linkedintwitter

Arix Bioscience plc, registered in England and Wales with company number 09777975

Registered office: 20 Berkeley Square, London W1J 6EQ, United Kingdom

Website by Ether